| Autor: |
Hosoda, Shunichi, Suda, Goki, Sho, Takuya, Ogawa, Koji, Kimura, Megumi, Yang, Zijian, Yoshida, Sonoe, Kubo, Akinori, Tokuchi, Yoshimasa, Kitagataya, Takashi, Maehara, Osamu, Ohnishi, Shunsuke, Nakamura, Akihisa, Yamada, Ren, Ohara, Masatsugu, Kawagishi, Naoki, Natsuizaka, Mitsuteru, Nakai, Masato, Morikawa, Kenichi, Furuya, Ken |
| Předmět: |
|
| Zdroj: |
Liver Cancer (2235-1795); 2023, Vol. 12 Issue 2, p1-15, 15p |
| Abstrakt: |
As shown in online supplementary Figure S8, similar to in vitro analysis, the median serum CXCL9 increased in patients with objective response to lenvatinib, and the median changes in serum CXCL9 were significantly higher in patients with objective response to lenvatinib than in those without objective response to lenvatinib. As shown in online supplementary Figure S3, the expression of CXCL9 in HCC was higher in patients with a high serum CXCL9 level compared with that in patients with a relatively lower serum CXCL9 level. As shown in Figure 2a, CXCL9 levels were significantly lower in patients with early PD compared to those in patients without early PD; while CXCL9 levels were similar in patients with or without objective responses. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
